Silent β-thalassemia: Transition Mutation of the β-globin Gene (Promoter nt-101 C>T)
Archives of Advances in Biosciences · 01.02.2023
DOI: 10.22037/aab.v13i.36666 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Advances in Biosciences, erschienen am 01.02.2023. Verfasst von Zeynab Gharehdaghi und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Heterozygote β-thalassemia is called carrier or β-thalassemia trait (BTT). Carriers have no clinical symptoms but sometimes have a mild anemia. They can often be identified with MCV 3.5 %. However, these tests are not enough to diagnose some unexpected beta-globin mutations in premarital or prenatal screening. Case Presentation: The mentioned case was one of the most common silent β-thalassemia mutations (promoter nt-101C>T).
Conclusion
It was the first report from Fars (Iran) and the second one from Iran. The case had normal hematologic indices and borderline hemoglobin A2 values that may be mistakenly interpreted as normal. The presented case showed that electrophoresis and PCR sequencing methods should be applied for screening thalassemia.
Schlagwörter
Zitieren
APA
Gharehdaghi, Z., Hosseinpouri, A., & Narges, O. (2023). Silent β-thalassemia: Transition Mutation of the β-globin Gene (Promoter nt-101 C>T). Archives of Advances in Biosciences. https://doi.org/10.22037/aab.v13i.36666
Vancouver
Gharehdaghi Z, Hosseinpouri A, Narges O. Silent β-thalassemia: Transition Mutation of the β-globin Gene (Promoter nt-101 C>T). Archives of Advances in Biosciences. 2023. doi:10.22037/aab.v13i.36666
BibTeX
@article{Gharehdaghi2023,
author = {Gharehdaghi, Zeynab and Hosseinpouri, Arghavan and Narges, Obeidi},
title = {Silent β-thalassemia: Transition Mutation of the β-globin Gene (Promoter nt-101 C>T)},
journal = {Archives of Advances in Biosciences},
year = {2023},
doi = {10.22037/aab.v13i.36666}
}
EUVIMED